相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Severe Infection in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Aladdin J. Mohammad et al.
JOURNAL OF RHEUMATOLOGY (2017)
Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature
William E. Monaco et al.
CLINICAL RHEUMATOLOGY (2016)
Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis
Andreas Kronbichler et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Richard A. Watts et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients
Ana Luisa Calich et al.
JOURNAL OF AUTOIMMUNITY (2014)
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
L. Guillevin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
Pierre Charles et al.
RHEUMATOLOGY (2014)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Infections in vasculitis
Loic Guillevin
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2013)
Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
Remi Goupil et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre
Emilio Besada et al.
RHEUMATOLOGY (2013)
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
Michael Walsh et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and Safety of Rituximab Treatment in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: Results from a German Registry (GRAID)
Petra Roll et al.
JOURNAL OF RHEUMATOLOGY (2012)
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis
Mary-Jane C. J. Guerry et al.
RHEUMATOLOGY (2012)
Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre
R. Pullerits et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Progress in treatment of ANCA-associated vasculitis
Rona M. Smith et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Long-term patient survival in ANCA-associated vasculitis
Oliver Flossmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
Loic Guillevin et al.
MEDICINE (2011)
Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis
Mark A. Little et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
Rachel B. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Kirsten de Groot et al.
ANNALS OF INTERNAL MEDICINE (2009)
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients
C. Charlier et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Rachel B. Jones et al.
ARTHRITIS AND RHEUMATISM (2009)
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa
Aladdin J. Mohammad et al.
RHEUMATOLOGY (2009)
Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden
A. J. Mohammad et al.
RHEUMATOLOGY (2007)
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
Richard Watts et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Predicting mortality in systemic Wegener's granulomatosis: A survival analysis based on 93 patients
D Bligny et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
分享论文
